Concepedia

C. van Groeningen

CV

6

Publications

595

Citations

6

H-Index

1998

Active since

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

Amsterdam UMC Location Vrije Universiteit Amsterdam

C. van Groeningen is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

1998–2009

6

Publications

6

Predictive Factors for Outcome in a Phase II Study of Gefitinib in Second-Line Treatment of Advanced Esophageal Cancer Patients

Maarten L. Janmaat, Mariëlle I. Gallegos-Ruiz, José Antonio Rodríguez et al. · Journal of Clinical Oncology · 2006 · 230 citations

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.

Stan B. Kaye, Graham M. Mead, Sophie D. Fosså et al. · Journal of Clinical Oncology · 1998 · 184 citations

Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas

Giuseppe Giaccone, Arun Rajan, Rita Ruijter et al. · Journal of Thoracic Oncology · 2009 · 112 citations · Full text

, , +7

Laparoscopic transhiatal resection for malignancies of the distal esophagus: Outcome of the first 50 resected patients

Joris J. Scheepers, Alexander A. F. A. Veenhof, Donald L. van der Peet et al. · Surgery · 2008 · 32 citations

, , +7

Gefitinib phase II study in second-line treatment of advanced esophageal cancer

C. van Groeningen, D. J. Richel, Giuseppe Giaccone · Journal of Clinical Oncology · 2004 · 24 citations

, , +15

Rows per page

1–5 of 6